Regulatory Filings • Mar 2, 2004
Regulatory Filings
Open in ViewerOpens in native device viewer
| C002 | קומפיוגן בע"מ | 2 | |
| Public | COMPUGEN LTD. | ||
| 2522 | Corporation no: 511779639 | ||
| Stock Exchange/Market: קומפיוגן | |||
| 606 | |||
| 380 | Pinchas Rosen 72 , Tel Aviv 69512 , , | ||
| Tel: 03-7658585 , 03-7658525 Fax: 03-7658555 | |||
| E.mail address: AYALA@COMPUGEN .CO.IL | Date of transmission: 02/03/2004 | ||
| Time of broadcast: 13:42 13:39:58 | |||
| Reference: 2004-02-074562 | |||
| Israel Securities Authority | Tel Aviv Stock Exchange | ||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.
| Attached hereto is a report on | 6-K regarding: Compugen Discovers Novel Soluble CD40 Protein |
CD40 Protein6-k_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous name of reporting entity: |
| Date of revision of form structure: 28/12/2003 |
| - - - |
| Name of the Signatory : Berler-Shapira Ayala Position of Signatory in the reporting corporation: Legal Counsel |
| Pinchas Rosen Telephone: 03-7658176 , Facsimile: 03-7658516 , E-mail: [email protected] |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.